Winship Cancer Institute of Emory University researchers found that treatment based on advanced molecular imaging can improve disease-free survival rates for men with prostate cancer with recurring cancer.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
